Primer: GC Biopharma Corp (006280 KS) - Aug 2026
GC Biopharma is poised for a significant earnings rebound in the second half of 2026, driven by the recognition of deferred revenues and strong...
104 Views
GC Biopharma (006280 KS/Buy)2Q26 Preview: Earnings Set to Improve in 2H
We expect GC Biopharma to post below-consensus 2Q26 results, with revenue of W418.7bn (-16.3% YoY; vs. consensus of W473.6bn) and operating profit...
113 Views
GC Biopharma (006280 KS) Alyglo Performance Beats Expectations
For 1Q26, GC Biopharma reported revenue of W435.5bn (+13.5% YoY) and operating profit of W11.7bn (+47% YoY), in line with market expectations.
122 Views
APAC Healthcare Weekly (Sept 13) – Hansoh, InSilico, Shionogi, Kyowa Kirin, Samsung Bio, SK Biopharm
Hansoh’s risvutatug rezetecan has been included in NMPA’s Priority Review. InSilico initiates rentosertib Phase 3 trial in IPF. Samsung Biologics...
96 Views
APAC Healthcare Weekly (Sept 6) – Simcere, Hutchmed, Akeso, Daiichi Sankyo, Alteogen, Pharmaessentia
Simcere and Hutchmend inked outlicensing deals with Roche and GSK, respectively. Akeso’s ivonescimab extends lives vs Keytruda. Alteogen inked...
103 Views